Flerie

Investment Holding Companies · Venture Capital
No open roles listed
Data updated Nov 21, 2026Full reportReport a mistake

Facts

as of Nov 21, 2026

Flerie is a Swedish life science investment company that takes active, long-term ownership positions in biotech and pharmaceutical companies. It invests globally in drug development companies, pharmaceutical service providers and medical technology, from early-stage ventures to listed holdings. Flerie was founded in 2011 by entrepreneur Thomas Eldered, co-founder of the pharmaceutical manufacturer Recipharm, and is based in Stockholm.

Legal name
Flerie Invest AB
Headquarters
Stockholm, Sweden
Founded
2011
Employees
1-10estimated range
Register numbers
ORGNR 5568566615
Website
flerie.com

These are the key facts about Flerie on Alion as of Nov 21, 2026. Flerie is headquartered in Stockholm, Sweden. It was founded in 2011.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Products

top 9%Web presenceof 133.2M domains by links, Common Crawl

What the registers and the postings say about this employer.

Legal entity active
Flerie Invest AB
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Stockholm SwedenHeadquarters0
Source: office addresses in postings and company registers

Newsroom

top 9%Web presenceof 133.2M domains by links, Common Crawl
Sources: the outlets named on each headline, each story once